Clinical Trial Update: Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer

View source ↗

Summary

A clinical trial update evaluating the cost-effectiveness of continuation maintenance therapy with six cycles of pemetrexed versus pemetrexed until disease prog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (Alimta) (pemetrexed)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Non-Small Cell Lung Cancer | Status: UNKNOWN